> Details

Zhang, Shijia; Shanley, Ryan; Weisdorf, Daniel J.; Rashidi, Armin

Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
  • Contributor: Zhang, Shijia; Shanley, Ryan; Weisdorf, Daniel J.; Rashidi, Armin
  • Published: American Society of Hematology, 2020
  • Published in: Blood Advances, 4 (2020) 12, Seite 2640-2643
  • Language: English
  • DOI: 10.1182/bloodadvances.2020001984
  • ISSN: 2473-9529; 2473-9537
  • Keywords: Hematology
  • Origination:
  • Footnote:
  • Description: <jats:title>Key Points</jats:title> <jats:p>Vancomycin exposure in the pre-engraftment period was associated with an increased risk for CMV reactivation after allogeneic HCT. Some gram-positive bacteria may protect against CMV reactivation.</jats:p>
  • Access State: Open Access